Grand River Selected for Operation Warp Speed Efforts
The CDMO will offer capacity for manufacturing and distributing COVID-19 vaccines and therapeutics at its Grand Rapids, MI, fill/finish facility.
Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization (CDMO), announced on August 6, 2020 that it has been chosen by the US Department of Health and Human Services and the US Department of Defense to support the US government’s Operation Warp Speed efforts by offering capacity for manufacturing and distributing COVID-19 vaccines and therapeutics.
Under the terms of the partnership, the government will reserve fill/finish capacity on a commercial filling line for use by federal partners that are developing COVID-19 vaccines or therapeutic treatments, a GRAM press release said. The company plans to use its 60,00-ft2 large-scale fill/finish facility located in Grand Rapids, MI, to aid in the pandemic efforts.
“We are extremely honored to be chosen to serve our country and help respond to the demands and challenges presented by the COVID-19 pandemic,” said Tom Ross, president and CEO of GRAM, in the press release. “As a homegrown company with a strong culture built on teamwork and accountability, our team will confidently deliver the safest and highest-quality solutions that will ultimately be life-saving for the American people.”
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
